Signifor (pasireotide diaspartate)
pCPA File Number:
20901
Negotiation Status:
Negotiations were not pursued
Indication(s):
Cushing's disease
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
SR0372-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: